Swedish PACS provider Sectra has received Food and Drug Administration clearance for its cardiovascular imaging analysis package.
The application features functions for quantifying arterial stenosis and overall heart function, including tools for quantitative coronary analysis (QCA) and left ventricle analysis (LVA), according to the Linkoping-based vendor.
By AuntMinnie.com staff writersMay 7, 2004
Related Reading
Sectra buys Mamea, April 30, 2004
Sectra pursues new financing, April 7, 2004
Sectra signs Karolinska, March 19, 2004
Viatronix, Sectra to show off integration, March 4, 2004
Sectra Q3 profits rise, March 2, 2004
Copyright © 2004 AuntMinnie.com